Abstract
Drosophila melanogaster is the most successful genetic model organism to study different human disease with a recent increased popularity to study neurological disorders. Drosophila melanogaster has a complex yet well-defined brain with defined anatomical regions with specific functions. The neuronal network in the adult brain has a structural organization highly similar to human neurons, but in a brain that is much more amenable for complex analyses. The availability of sophisticated genetic tools to study neurons permits to examine neuronal functions at the single cell level in the whole brain by confocal imaging, which does not require sections. Thus, Drosophila has been used to successfully study many neurological disorders such as Parkinson’s disease and has been recently adopted to understand the complex networks leading to neurological disorders with metabolic origins such as Leigh disease and X-linked adrenoleukodystrophy (X-ALD).
In this review, we will describe the genetic tools available to study neuronal structures and functions and also illustrate some limitations of the system. Finally, we will report the experimental efforts that in the past 10 years have established Drosophila melanogaster as an excellent model organism to study neurodegenerative disorders focusing on X-ALD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ugur B, Chen K, Bellen HJ (2016) Drosophila tools and assays for the study of human diseases. Dis Model Mech 9(3):235–244
Herman MM, Miquel J, Johnson M (1971) Insect brain as a model for the study of aging. Age-related changes in drosophila melanogaster. Acta Neuropathol 19(3):167–183
Jackson GR et al (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21(3):633–642
Finelli A et al (2004) A model for studying Alzheimer’s Abeta42-induced toxicity in Drosophila melanogaster. Mol Cell Neurosci 26(3):365–375
Feany MB, Bender WW (2000) A drosophila model of Parkinson’s disease. Nature 404(6776):394–398
Hales KG et al (2015) Genetics on the Fly: a primer on the Drosophila model system. Genetics 201(3):815–842
McGurk L, Berson A, Bonini NM (2015) Drosophila as an in vivo model for human neurodegenerative disease. Genetics 201(2):377–402
Wangler MF, Hu Y, Shulman JM (2017) Drosophila and genome-wide association studies: a review and resource for the functional dissection of human complex traits. Dis Model Mech 10(2):77–88
Jha SK et al (2017) Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration. Biochim Biophys Acta Mol basis Dis 1863(5):1132–1146
Zilberter Y, Zilberter M (2017) The vicious circle of hypometabolism in neurodegenerative diseases: ways and mechanisms of metabolic correction. J Neurosci Res 95(11):2217–2235
Pierre G (2013) Neurodegenerative disorders and metabolic disease. Arch Dis Child 98(8):618–624
Sambamoorthy G, Raman K (2018) Understanding the evolution of functional redundancy in metabolic networks. Bioinformatics 34(17):i981–i987
Mast FD et al (2011) A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders. Dis Model Mech 4(5):659–672
Sivachenko A et al (2016) Neurodegeneration in a Drosophila model of adrenoleukodystrophy: the roles of the bubblegum and double bubble acyl-CoA synthetases. Dis Model Mech 9(4):377–387
Min KT, Benzer S (1999) Preventing neurodegeneration in the drosophila mutant bubblegum. Science 284(5422):1985–1988
Gordon HB, Valdez L, Letsou A (2018) Etiology and treatment of adrenoleukodystrophy: new insights from Drosophila. Dis Model Mech 11(6):dmm031286
Steinberg SJ et al (2000) Very long-chain acyl-CoA synthetases. Human "bubblegum" represents a new family of proteins capable of activating very long-chain fatty acids. J Biol Chem 275(45):35162–35169
Brayne C, Miller B (2017) Dementia and aging populations-a global priority for contextualized research and health policy. PLoS Med 14(3):e1002275
Fulop T et al (2017) Immunosenescence and Inflamm-aging as two sides of the same coin: friends or foes? Front Immunol 8:1960
Garschall K, Flatt T (2018) The interplay between immunity and aging in drosophila. F1000Res 7:160
Kounatidis I et al (2017) NF-kappaB immunity in the brain determines Fly lifespan in healthy aging and age-related Neurodegeneration. Cell Rep 19(4):836–848
Li S, Yu X, Feng Q (2019) Fat body biology in the last decade. Annu Rev Entomol 64:315–333
Matsuda S, Kitagishi Y, Kobayashi M (2013) Function and characteristics of PINK1 in mitochondria. Oxidative Med Cell Longev 2013:601587
Riley BE et al (2013) Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat Commun 4:1982
Clark IE et al (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441(7097):1162–1166
Park J et al (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441(7097):1157–1161
Kim Y et al (2008) PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 377(3):975–980
Wang C et al (2007) Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities. J Neurosci 27(32):8563–8570
Lee JJ et al (2018) Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin. J Cell Biol 217(5):1613–1622
Julienne H et al (2017) Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson’s disease phenotypes. Neurobiol Dis 104:15–23
De Lazzari F et al (2018) Circadian rhythm abnormalities in Parkinson’s disease from humans to flies and Back. Int J Mol Sci 19:12
St Johnston D (2002) The art and design of genetic screens: Drosophila melanogaster. Nat Rev Genet 3(3):176–188
Burnouf S et al (2016) Deletion of endogenous Tau proteins is not detrimental in Drosophila. Sci Rep 6:23102
McInnes J et al (2018) Synaptogyrin-3 mediates presynaptic dysfunction induced by Tau. Neuron 97(4):823–835 e8
Ray A, Speese SD, Logan MA (2017) Glial Draper rescues Abeta toxicity in a Drosophila model of Alzheimer’s disease. J Neurosci 37(49):11881–11893
Watson MR et al (2008) A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem 283(36):24972–24981
Ordonez DG, Lee MK, Feany MB (2018) Alpha-synuclein induces mitochondrial dysfunction through Spectrin and the actin cytoskeleton. Neuron 97(1):108–124 e6
Olsen AL, Feany MB (2019) Glial alpha-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo. Glia 67(10):1933–1957
Freeman MR (2015) Drosophila central nervous system glia. Cold Spring Harb Perspect Biol 7(11):a020552
White JG et al (1986) The structure of the nervous system of the nematode Caenorhabditis elegans. Philos Trans R Soc Lond Ser B Biol Sci 314(1165):1–340
Takemura SY et al (2017) The comprehensive connectome of a neural substrate for ‘ON’ motion detection in Drosophila. elife 6:e24394
Fu H, Hardy J, Duff KE (2018) Selective vulnerability in neurodegenerative diseases. Nat Neurosci 21(10):1350–1358
Ito K et al (2014) A systematic nomenclature for the insect brain. Neuron 81(4):755–765
Strausfeld NJ, Hirth F (2013) Deep homology of arthropod central complex and vertebrate basal ganglia. Science 340(6129):157–161
St Pierre SE et al (2014) FlyBase 102--advanced approaches to interrogating FlyBase. Nucleic Acids Res 42(Database issue):D780–D788
Waddell S (2010) Dopamine reveals neural circuit mechanisms of fly memory. Trends Neurosci 33(10):457–464
Thum AS, Gerber B (2019) Connectomics and function of a memory network: the mushroom body of larval Drosophila. Curr Opin Neurobiol 54:146–154
Riemensperger T et al (2013) A single dopamine pathway underlies progressive locomotor deficits in a Drosophila model of Parkinson disease. Cell Rep 5(4):952–960
Nagoshi E (2018) Drosophila models of sporadic Parkinson’s disease. Int J Mol Sci 19:11
Rubin GM et al (2000) Comparative genomics of the eukaryotes. Science 287(5461):2204–2215
Bier E (2005) Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 6(1):9–23
Adams MD et al (2000) The genome sequence of Drosophila melanogaster. Science 287(5461):2185–2195
Greenspan RJ, Dierick HA (2004) ‘Am not I a fly like thee?’ from genes in fruit flies to behavior in humans. Hum Mol Genet 13(2):R267–R273
Baek KH (1999) The first oncogene in Drosophila melanogaster. Mutat Res 436(2):131–136
Nusslein-Volhard C, Wieschaus E (1980) Mutations affecting segment number and polarity in drosophila. Nature 287(5785):795–801
Tataroglu O, Emery P (2014) Studying circadian rhythms in Drosophila melanogaster. Methods 68(1):140–150
Lemaitre B et al (1996) The dorsoventral regulatory gene cassette spatzle/toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86(6):973–983
Kleino A, Silverman N (2014) The Drosophila IMD pathway in the activation of the humoral immune response. Dev Comp Immunol 42(1):25–35
Boutros M, Ahringer J (2008) The art and design of genetic screens: RNA interference. Nat Rev Genet 9(7):554–566
Cook KR et al (2010) New research resources at the Bloomington Drosophila Stock Center. Fly (Austin) 4(1):88–91
Ni JQ et al (2011) A genome-scale shRNA resource for transgenic RNAi in Drosophila. Nat Methods 8(5):405–407
Dietzl G et al (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in drosophila. Nature 448(7150):151–156
Drozd M, Bardoni B, Capovilla M, Modeling Fragile X (2018) Syndrome in Drosophila. Front Mol Neurosci 11:124
Johnson SL et al (2019) Differential toxicity of ataxin-3 isoforms in drosophila models of Spinocerebellar ataxia type 3. Neurobiol Dis 132:104535
Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118(2):401–415
Jenett A et al (2012) A GAL4-driver line resource for Drosophila neurobiology. Cell Rep 2(4):991–1001
Pfeiffer BD et al (2008) Tools for neuroanatomy and neurogenetics in Drosophila. Proc Natl Acad Sci U S A 105(28):9715–9720
Luan H et al (2006) Refined spatial manipulation of neuronal function by combinatorial restriction of transgene expression. Neuron 52(3):425–436
Auluck PK et al (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295(5556):865–868
Kim NC et al (2013) VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron 78(1):65–80
Li LB et al (2008) RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453(7198):1107–1111
Kazemi-Esfarjani P, Benzer S (2000) Genetic suppression of polyglutamine toxicity in drosophila. Science 287(5459):1837–1840
Madabattula ST et al (2015) Quantitative analysis of climbing defects in a Drosophila model of neurodegenerative disorders. J Vis Exp 100:e52741
del Valle Rodriguez A, Didiano D, Desplan C (2011) Power tools for gene expression and clonal analysis in Drosophila. Nat Methods 9(1):47–55
Simpson JH, Looger LL (2018) Functional imaging and Optogenetics in Drosophila. Genetics 208(4):1291–1309
Nakai J, Ohkura M, Imoto K (2001) A high signal-to-noise Ca(2+) probe composed of a single green fluorescent protein. Nat Biotechnol 19(2):137–141
Siegel MS, Isacoff EY (1997) A genetically encoded optical probe of membrane voltage. Neuron 19(4):735–741
Feinberg EH et al (2008) GFP reconstitution across synaptic partners (GRASP) defines cell contacts and synapses in living nervous systems. Neuron 57(3):353–363
Lee D et al (2017) Methods to investigate the structure and connectivity of the nervous system. Fly (Austin) 11(3):224–238
Sun S, Yu R, Wang S (2017) A neural signature encoding decisions under perceptual ambiguity. eNeuro 4(6):ENEURO.0235-17.2017
Hwang RY et al (2007) Nociceptive neurons protect Drosophila larvae from parasitoid wasps. Curr Biol 17(24):2105–2116
Moser HW, Raymond GV, Dubey P (2005) Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA 294(24):3131–3134
Mosser J et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361(6414):726–730
Vasiliou V, Vasiliou K, Nebert DW (2009) Human ATP-binding cassette (ABC) transporter family. Hum Genomics 3(3):281–290
Morita M, Imanaka T (2012) Peroxisomal ABC transporters: structure, function and role in disease. Biochim Biophys Acta 1822(9):1387–1396
Kobayashi T et al (1997) Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 232(3):631–636
Forss-Petter S et al (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50(5):829–843
Moser HW, SKD, Moser AB, In The metabolic and molecular bases of inherited disease, E. C. R. Scriver et al. 1995, McGraw-Hill,: New York. p. 2325–2349
Grevengoed TJ, Klett EL, Coleman RA (2014) Acyl-CoA metabolism and partitioning. Annu Rev Nutr 34:1–30
Meloni I et al (2002) FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet 30(4):436–440
Liu Z et al (2011) Drosophila acyl-CoA synthetase long-chain family member 4 regulates axonal transport of synaptic vesicles and is required for synaptic development and transmission. J Neurosci 31(6):2052–2063
Golej DL et al (2011) Long-chain acyl-CoA synthetase 4 modulates prostaglandin E(2) release from human arterial smooth muscle cells. J Lipid Res 52(4):782–793
Dourlen P et al (2015) Fatty acid transport proteins in disease: new insights from invertebrate models. Prog Lipid Res 60:30–40
Gordon HB, Letsou A, Bonkowsky JL (2014) The leukodystrophies. Semin Neurol 34(3):312–320
Wanders RJ et al (1998) X-linked adrenoleukodystrophy: improved prenatal diagnosis using both biochemical and immunological methods. J Inherit Metab Dis 21(3):285–287
Jia Z et al (2004) X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases. Mol Genet Metab 83(1-2):117–127
Fraisl P et al (2004) Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase. Biochem J 377(1):85–93
Pei Z, Jia Z, Watkins PA (2006) The second member of the human and murine bubblegum family is a testis- and brainstem-specific acyl-CoA synthetase. J Biol Chem 281(10):6632–6641
Sellin J et al (2018) Dietary rescue of lipotoxicity-induced mitochondrial damage in Peroxin19 mutants. PLoS Biol 16(6):e2004893
Heinzer AK et al (2003) A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum Mol Genet 12(10):1145–1154
Wiesinger C et al (2013) Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J Biol Chem 288(26):19269–19279
Acknowledgments
We would like to thank the Natural Sciences and Engineering Research Council of Canada, the Dalhousie Medical Research Foundation and Research Nova Scotia, and the German Research Foundation (DFG) for supporting this work.
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bülow, M.H., Parsons, B.D., Di Cara, F. (2020). The Drosophila melanogaster as Genetic Model System to Dissect the Mechanisms of Disease that Lead to Neurodegeneration in Adrenoleukodystrophy. In: Lizard, G. (eds) Peroxisome Biology: Experimental Models, Peroxisomal Disorders and Neurological Diseases. Advances in Experimental Medicine and Biology, vol 1299. Springer, Cham. https://doi.org/10.1007/978-3-030-60204-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-60204-8_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-60203-1
Online ISBN: 978-3-030-60204-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)


